Real-world outcomes of patients with relapsed refractory multiple myeloma treated with commercial bispecific T-cell engager antibodies: a single center experience.

Lindsay Fogel, Patrick C Roney, Jaeil Ahn, Adolfo Aleman, Fideliza Perez-Manon, Natalie Arias-Orozco, Gabriella Monteleone, Kiara Londono, Kathleen Builes, Palka Anand, Harsh Parmar, Pooja Phull, David Vesole, David S Siegel, Andrew Ip